Journal article
CMET-47. PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES
Abstract
Brain Metastases (BM) are the most common neoplasm to affect the adult central nervous system, occurring at a rate 10 times greater than that of primary brain cancers. Despite the prevalence and severe lethality of BM, therapeutic strategies remain limited. Advancements in in vivo modelling of metastasis presents a useful platform to aid in the advance and screening of novel targeting therapeutics, though currently few models exist that …
Authors
Singh M; Venugopal C; Tokar T; McFarlane N; Bakhshinyan D; Qazi M; Vora P; Murty N; Jurisica I; Singh S
Journal
Neuro-Oncology, Vol. 19, No. suppl_6, pp. vi49–vi49
Publisher
Oxford University Press (OUP)
Publication Date
November 6, 2017
DOI
10.1093/neuonc/nox168.193
ISSN
1522-8517